Osteosarcoma cells depend on MCL-1 for survival, and osteosarcoma metastases respond to MCL-1 antagonism plus regorafenib in vivo

Yanhao Ji(La Trobe University), Christine J. Hawkins(La Trobe University)
BMC Cancer
November 4, 2024
Cited by 6


Related Papers